If you plan to use a cover letter in a job application, ensure you personalise it so that it highlights why you're the best fit for a role. See these tips from experts on LinkedIn.
Visitors find China "is not what the media describes," Chinese Consul General in New York Chen Li said in an interview. "It’s ...
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
The Russian drugmaker Axelpharm will continue sales of its drug axitinib, which is used in kidney cancer therapy and is a generic of version of US pharma giant Pfizer’s (NYSE: PFE) Inlyta, reports The ...
Arvinas and Pfizer’s targeted protein degrader has not managed to distinguish itself from other, similar breast cancer drugs, according to pivotal data re ...
Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...
Those same rules apply to the remit of an undercover cop. Enter Deep Cover, an upcoming crime comedy in which three improv comedians are recruited by the police as undercover operatives.
Weiner had the idea to splatter an 18-year-old Gigi with acrylic paint and shoot her for a series she called Cover, Girl. “We put her in my little Chinatown apartment shower. There was hardly ...
“I feel that as a model, I’m a performer,” says Gigi Hadid in our April cover story, and you can see those instincts at work in the Jazz Age-inspired photographs by Annie Leibovitz that ...
Arvinas’ stock took a 43% tumble on the news, and analysts are downcast on the drug’s prospects. Pfizer and Arvinas’ investigational PRTOAC degrader vepdegestrant can improve progression-free survival ...
Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ups and downs in between, after it took a hammering in the past couple ...
Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback